Will New Healthcare Policy Impact Value-Based Healthcare?
The final days of 2016 were fraught with uncertainty about what Congress and the new Trump Administration would do to the Affordable Care Act (ACA) and the healthcare regulatory landscape overall. So far, in 2017, we do not have much more clarity. Repeal, repeal and replace, repeal and delay, modify without repeal—there are now even more questions than answers and still no consensus Republican plan in sight. Yet healthcare executives would certainly appreciate some modicum of clarity, at least on the narrower topic of whether the shift to value-based healthcare models will continue under whatever new system is coming. This webinar attempts to add clarity by analyzing what we know so far, as reflected in the limited actual evidence that is available.Join Dan Orenstein, General Counsel, Health Catalyst, as he analyzes these three key pieces of information:
- The 21st Century Cures Act (Cures)
- The Executive Order on reducing the “burden” of the Affordable Care Act (ACA)
- Tom Price’s comments at his confirmation hearings